Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Drewinko

Showing results (121-130 of 188) with videos related to

Pageof 19
Sort By:
Blood|February 1, 1981
The growth fraction of human myeloma cellsB Drewinko, R Alexanian, H Boyer, et al.
Investigational New Drugs|January 1, 1984
Responses of human bone marrow progenitor cells to fluoro-ara-AMP, homoharringtonine, and elliptiniumG E Umbach, V Hug, G Spitzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Pancreatic carcinoma and Trousseau's syndrome: experience at a large cancer centerR Pinzon, B Drewinko, J M Trujillo, et al.
Cancer Research|March 1, 1984
Normalization of in vitro sensitivity testing of human tumor clonogenic cellsV Hug, H Thames, G R Blumenschein, et al.
Breast Cancer Research and Treatment|January 1, 1985
Medroxyprogesterone acetate does not protect human bone marrow progenitor cells exposed to adriamycin in vitroG E Umbach, G Spitzer, B Drewinko, et al.
Cell and Tissue Kinetics|March 1, 1981
A rapid automated stathmokinetic method for determination of in vitro cell cycle transit timesG M Dosik, B Barlogie, R A White, et al.
Cancer Research|November 1, 1979
In vitro cytokinetic response of human colon cancer cells to cis-dichlorodiammineplatinum(II)J P Bergerat, B Barlogie, W Göhde, et al.
Journal of the National Cancer Institute|October 1, 1973
Brief communication: Specific colony inhibition by human lymphoma cells on an established human lymphoma cell lineB Drewinko, G Mavligit, U Ambus, et al.
Cancer|November 1, 1984
ARH-77, an established human IgG-producing myeloma cell line. I. Morphology, B-cell phenotypic marker profile, and expression of Epstein-Barr virusB Drewinko, W Mars, J Minowada, et al.
Cancer Treatment Reports|March 1, 1982
Serial analysis of melanoma growth kinetics in a patient receiving bleomycin and procarbazine therapy: comparison of tumor volume, flow cytometry, and thymidine labeling techniquesJ J Stragand, B Drewinko, B Barlogie, et al.
Pageof 19

Showing results (121-130 of 188) with videos related to

Sort By:
Pageof 19
Blood|February 1, 1981
The growth fraction of human myeloma cellsB Drewinko, R Alexanian, H Boyer, et al.
Investigational New Drugs|January 1, 1984
Responses of human bone marrow progenitor cells to fluoro-ara-AMP, homoharringtonine, and elliptiniumG E Umbach, V Hug, G Spitzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Pancreatic carcinoma and Trousseau's syndrome: experience at a large cancer centerR Pinzon, B Drewinko, J M Trujillo, et al.
Cancer Research|March 1, 1984
Normalization of in vitro sensitivity testing of human tumor clonogenic cellsV Hug, H Thames, G R Blumenschein, et al.
Breast Cancer Research and Treatment|January 1, 1985
Medroxyprogesterone acetate does not protect human bone marrow progenitor cells exposed to adriamycin in vitroG E Umbach, G Spitzer, B Drewinko, et al.
Cell and Tissue Kinetics|March 1, 1981
A rapid automated stathmokinetic method for determination of in vitro cell cycle transit timesG M Dosik, B Barlogie, R A White, et al.
Cancer Research|November 1, 1979
In vitro cytokinetic response of human colon cancer cells to cis-dichlorodiammineplatinum(II)J P Bergerat, B Barlogie, W Göhde, et al.
Journal of the National Cancer Institute|October 1, 1973
Brief communication: Specific colony inhibition by human lymphoma cells on an established human lymphoma cell lineB Drewinko, G Mavligit, U Ambus, et al.
Cancer|November 1, 1984
ARH-77, an established human IgG-producing myeloma cell line. I. Morphology, B-cell phenotypic marker profile, and expression of Epstein-Barr virusB Drewinko, W Mars, J Minowada, et al.
Cancer Treatment Reports|March 1, 1982
Serial analysis of melanoma growth kinetics in a patient receiving bleomycin and procarbazine therapy: comparison of tumor volume, flow cytometry, and thymidine labeling techniquesJ J Stragand, B Drewinko, B Barlogie, et al.
Pageof 19